News
VANCOUVER, BC / ACCESS Newswire / June 20, 2025 / Onco-Innovations Limited(CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that the Co-Founders of ...
VANCOUVER, BC / ACCESS Newswire / June 20, 2025 / Onco-Innovations Limited(CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that the Co-Founders of ...
EarlyHealth Group (EHG), a global pharmaceutical company, and The University of the West Indies (The UWI) have announced a ...
Embrace the chaos of trial and error; it’s the fertile ground where creativity ... A study published in the Journal of Social ...
11h
AllAfrica on MSNNigeria: Sickle Cell Day - Patients Battle High Cost of Drugs, Access to TreatmentPeople living with Sickle Cell Disease (SCD) in Nigeria have lamented that the high cost of medication and poor access to comprehensive care are weighing heavily on them and their families.
19h
Axios on MSNThe Colts' legacy of leadershipThe Colts' new owners are committed to keeping the franchise a family business. Why it matters: Carlie Irsay-Gordon, Casey ...
A twice-yearly injection of lenacapavir would offer near-complete protection against the virus, clinical date indicate. More pharmaceutical news is about Dupixent, GLP-1 results, and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results